AI English summary of an SEC filing — figures as filed
Zimmer Biomet entered into an underwriting agreement with Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, as representatives of the underwriters, for the public offering of $700.0 million in aggregate principal amount of 5.200% notes due 2034. The company said it entered into the agreement on August 8, 2024.
Key points
AI summaryZimmer Biomet entered into an underwriting agreement with Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, as representatives of the underwriters, for the public offering of $700.0 million in aggregate principal amount of 5.200% notes due 2034. The company said it entered into the agreement on August 8, 2024.
The company said the notes will bear interest at 5.200% per year, payable semi-annually in arrears on March 15 and September 15 of each year, with the first interest payment on March 15, 2025. The notes will mature on September 15, 2034.
The company said the sale of the notes is scheduled to close on August 15, 2024, subject to customary closing conditions. The underwriting agreement contains customary representations, warranties, covenants and conditions, and the company agreed to indemnify the underwriters against certain liabilities on customary terms.
The company said that if a portion of the net proceeds is used to repay borrowings under its credit facilities, or to repay at maturity, redeem or otherwise retire a portion of its 1.450% notes due 2024, some of the underwriters and their affiliates would receive a share of those proceeds as lenders or holders.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Zimmer Biomet prices $700.0 million 5.200% notes due 2034 underwriting agreement
Zimmer Biomet entered into an underwriting agreement with Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, as representatives of the underwriters, for the public offering of $700.0 million in aggregate principal amount of 5.200% notes due 2034. The company said it entered into the agreement on August 8, 2024.
Source · Based on the filing body and exhibits
Notes interest rate, maturity and payment schedule
The company said the notes will bear interest at 5.200% per year, payable semi-annually in arrears on March 15 and September 15 of each year, with the first interest payment on March 15, 2025. The notes will mature on September 15, 2034.
Source · Based on the filing body and exhibits
Expected closing date and underwriting agreement terms
The company said the sale of the notes is scheduled to close on August 15, 2024, subject to customary closing conditions. The underwriting agreement contains customary representations, warranties, covenants and conditions, and the company agreed to indemnify the underwriters against certain liabilities on customary terms.
Source · Based on the filing body and exhibits
Use of net proceeds and underwriter interests
The company said that if a portion of the net proceeds is used to repay borrowings under its credit facilities, or to repay at maturity, redeem or otherwise retire a portion of its 1.450% notes due 2024, some of the underwriters and their affiliates would receive a share of those proceeds as lenders or holders.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…